IL6 and myocardial infarction: Interestingly, even in patients referred for coronary revascularization, preprocedural administration of colchicine, reduced inflammation markers such as CRP and IL-6, but did not affect the risk for percutaneous coronary intervention (PCI)-related MI [116].